Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.870
+0.080 (4.47%)
At close: Oct 4, 2024, 4:00 PM
1.852
-0.018 (-0.96%)
After-hours: Oct 4, 2024, 6:37 PM EDT
Caribou Biosciences Stock Forecast
CRBU's stock price has decreased by -59.61% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Caribou Biosciences stock have an average target of 14, with a low estimate of 9.00 and a high estimate of 19. The average target predicts an increase of 648.66% from the current stock price of 1.87.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 3, 2024.
Analyst Ratings
The average analyst rating for CRBU stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +381.28% | Sep 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +381.28% | Aug 14, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $14 | Buy | Reiterates | $14 | +648.66% | Aug 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +381.28% | Jul 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $24 → $9 | Strong Buy | Maintains | $24 → $9 | +381.28% | Jun 4, 2024 |
Financial Forecast
Revenue This Year
12.67M
from 34.48M
Decreased by -63.27%
Revenue Next Year
13.08M
from 12.67M
Increased by 3.24%
EPS This Year
-1.81
from -1.38
EPS Next Year
-2.09
from -1.81
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 17.7M | 23.2M | 226.5M | ||
| Avg | 12.7M | 13.1M | 74.7M | ||
| Low | 5.8M | n/a | 9.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -48.5% | 83.2% | 1,632.5% | ||
| Avg | -63.3% | 3.2% | 471.3% | ||
| Low | -83.2% | - | -25.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.73 | -1.77 | -0.69 | ||
| Avg | -1.81 | -2.09 | -1.78 | ||
| Low | -1.90 | -2.86 | -2.72 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.